Congenital Clinical Trials

1 recruiting

Congenital Trials at a Glance

319 actively recruiting trials for congenital are listed on ClinicalTrialsFinder across 6 cities in 52 countries. The largest study group is Not Applicable with 105 trials, with the heaviest enrollment activity in Paris, Boston, and Los Angeles. Lead sponsors running congenital studies include Boston Children's Hospital, IRCCS Azienda Ospedaliero-Universitaria di Bologna, and Assistance Publique - Hôpitaux de Paris.

Browse congenital trials by phase

Treatments under study

About Congenital Clinical Trials

Looking for clinical trials for Congenital? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Congenital trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Congenital clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 319 trials

Recruiting
Phase 1

A Safety Assessment of Oral Letermovir in Infants With Symptomatic Congenital Cytomegalovirus

Congenital Cytomegalovirus Infection
National Institute of Allergy and Infectious Diseases (NIAID)12 enrolled10 locationsNCT06118515
Recruiting
Not Applicable

Starlight Cardiovascular Lifeline Ductus Arteriosus Stent IDE Study

Congenital Heart DiseaseCongenital Heart Disease (CHD)
Starlight Cardiovascular Inc35 enrolled8 locationsNCT07114718
Recruiting

Natural History of Noncirrhotic Portal Hypertension

Cystic FibrosisTurner SyndromeImmunologic Deficiency Syndrome+2 more
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)400 enrolled1 locationNCT02417740
Recruiting
Not Applicable

Genes Associated With Development of Pulmonary Arterial Hypertension in Patients With Congenital Shunt Lesions

Genetic TestingPulmonary Arterial HypertensionHeart Defects, Congenital
Universitaire Ziekenhuizen KU Leuven21 enrolled1 locationNCT02691689
Recruiting
Phase 2Phase 3

A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)

Congenital Adrenal HyperplasiaClassic Congenital Adrenal Hyperplasia
Crinetics Pharmaceuticals Inc.153 enrolled32 locationsNCT07159841
Recruiting
Phase 3

A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia

Congenital Adrenal HyperplasiaClassic Congenital Adrenal Hyperplasia
Crinetics Pharmaceuticals Inc.150 enrolled26 locationsNCT07144163
Recruiting
Phase 2

18FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism

Congenital Hyperinsulinism
Miguel Pampaloni50 enrolled1 locationNCT04205604
Recruiting
Not Applicable

A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines

Chronic Kidney DiseaseProteinuriaBlood Pressure Control+2 more
St. James's Hospital, Ireland80 enrolled2 locationsNCT07561957
Recruiting
Not Applicable

Implementation of an Accessible Healthcare Model (ACHD STRONG): Comparing Nurse and Physician Lead Healthcare Transition Education in a RE-AIM Framework

Congenital Heart Disease
University of Wisconsin, Madison450 enrolled1 locationNCT07559253
Recruiting
Not Applicable

HFNC vs NIPPV Following Extubation

Congenital Heart Disease
Emory University200 enrolled1 locationNCT05869825
Recruiting

Natural History Study of Patients With Excess Androgen

Congenital Adrenal Hyperplasia (CAH)Familial Male-Limited Precocious Puberty (FMPP)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3,000 enrolled2 locationsNCT00250159
Recruiting

A Natural History Study in Participants With Congenital Myasthenic Syndromes (CMS) Due to Mutations in DOK7, MUSK, AGRN, or LRP4

Congenital Myasthenic Syndrome
argenx100 enrolled20 locationsNCT06078553
Recruiting

NeoDoppler: New Ultrasound Technology for Continuous Monitoring of Cerebral Circulation Pilot

SepsisStrokePulmonary Hypertension+4 more
St. Olavs Hospital180 enrolled1 locationNCT06646250
Recruiting
Phase 4

Continuous vs Intermittent Ketorolac for Pain Control in Peds CV Surgery

Congenital Heart Disease in Children
Phoenix Children's Hospital166 enrolled1 locationNCT04040452
Recruiting
Phase 1

A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS)

Congenital Myasthenic SyndromeCMS
argenx16 enrolled9 locationsNCT06436742
Recruiting
Not Applicable

A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD Study

Patient-Reported Outcome Measures (PROMs)Pragmatic TrialAdolescent Congenital Heart Disease+1 more
Carelon Research390 enrolled14 locationsNCT07525843
Recruiting

KIDSHEART AND BRAIN : Early EEG Surgery Congenital Heart Disease Predict Onset of Neurodevelopmental Disorders

Neurodevelopmental DisordersCongenital Cardiomyopathy
University Hospital, Lille50 enrolled1 locationNCT05658965
Recruiting
Not Applicable

Online Support 4 CHD Kids & Caregivers

Congenital Heart Disease
The Hospital for Sick Children382 enrolled1 locationNCT06075251
Recruiting
Not Applicable

Prospective Registry for Long-term Outcomes Following FETO in Severe Left and Right CDH

HerniaCongenital Diaphragmatic HerniaInternal Hernia+5 more
Johns Hopkins University80 enrolled1 locationNCT07166172
Recruiting

International Study of Cerebral Oxygenation and Electrical Activity During Major Neonatal Surgery

Congenital DisordersCerebral Desaturation
Children's Hospital of Philadelphia900 enrolled15 locationsNCT05673499